Beyond EGFR’s classical role in promoting glioma cell proliferation and survival through the activation of oncogenic PI3K, AKT and RAS/MAPK pathways, EGFR overexpression has been linked with macrophages recruitment in GBM and breast cancer [88, 89]. Here, AKT1 is linked to glioma.